ReviewVaccines2017

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue Architecture.

Federico Garrido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.